These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 27531512)

  • 1. Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model.
    Lowrence RC; Raman T; Makala HV; Ulaganathan V; Subramaniapillai SG; Kuppuswamy AA; Mani A; Chittoor Neelakantan S; Nagarajan S
    Appl Microbiol Biotechnol; 2016 Nov; 100(21):9265-9281. PubMed ID: 27531512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo.
    Sundaramoorthy NS; Mitra K; Ganesh JS; Makala H; Lotha R; Bhanuvalli SR; Ulaganathan V; Tiru V; Sivasubramanian A; Nagarajan S
    Microb Pathog; 2018 Nov; 124():54-62. PubMed ID: 30118803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
    Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
    Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
    J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of expression of NorA efflux pump in ciprofloxacin resistant Staphylococcus aureus against hexahydroquinoline derivative by real-time PCR.
    Pourmand MR; Yousefi M; Salami SA; Amini M
    Acta Med Iran; 2014; 52(6):424-9. PubMed ID: 25130148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
    Fontaine F; Héquet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
    Eur J Med Chem; 2015 May; 95():185-98. PubMed ID: 25817769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
    Kalia NP; Mahajan P; Mehra R; Nargotra A; Sharma JP; Koul S; Khan IA
    J Antimicrob Chemother; 2012 Oct; 67(10):2401-8. PubMed ID: 22807321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NorA efflux pump inhibitory activity of coumarins from Mesua ferrea.
    Roy SK; Kumari N; Pahwa S; Agrahari UC; Bhutani KK; Jachak SM; Nandanwar H
    Fitoterapia; 2013 Oct; 90():140-50. PubMed ID: 23892000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of efflux pump genes mediating ciprofloxacin and antiseptic resistance in methicillin-resistant Staphylococcus aureus isolates.
    Hassanzadeh S; Mashhadi R; Yousefi M; Askari E; Saniei M; Pourmand MR
    Microb Pathog; 2017 Oct; 111():71-74. PubMed ID: 28826767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unlocking bacterial defense: Exploring the potent inhibition of NorA efflux pump by coumarin derivatives in Staphylococcus aureus.
    Martin ALAR; Pereira RLS; Rocha JE; Farias PAM; Freitas TS; Caldas FRL; Figueredo FG; Sampaio NFL; Oliveira-Tintino CDM; Tintino SR; da Hora GCA; Lima MCP; de Menezes IRA; Carvalho DT; Coutinho HDM; Fonteles MMF
    Microb Pathog; 2024 May; 190():106608. PubMed ID: 38503396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
    Naaz F; Khan A; Kumari A; Ali I; Ahmad F; Ahmad Lone B; Ahmad N; Ali Khan I; Rajput VS; Grover A; Shafi S
    Bioorg Chem; 2021 Aug; 113():105031. PubMed ID: 34089943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Update on
    Monteiro KLC; de Aquino TM; Mendonça Junior FJB
    Curr Top Med Chem; 2020; 20(24):2168-2185. PubMed ID: 32621719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel dihydronaphthalene-imidazole ligands as potential inhibitors of Staphylococcus aureus multidrug resistant NorA efflux pump: A combination of experimental and in silico molecular docking studies.
    A Malik A; Dangroo NA; Kaur P; Attery S; A Rather M; Khan A; Ara T; Nandanwar H
    Microb Pathog; 2024 May; 190():106627. PubMed ID: 38521473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
    Zhang J; Sun Y; Wang Y; Lu M; He J; Liu J; Chen Q; Zhang X; Zhou F; Wang G; Sun X
    Eur J Pharmacol; 2014 Oct; 740():277-84. PubMed ID: 25054686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.
    Vidaillac C; Guillon J; Arpin C; Forfar-Bares I; Ba BB; Grellet J; Moreau S; Caignard DH; Jarry C; Quentin C
    Antimicrob Agents Chemother; 2007 Mar; 51(3):831-8. PubMed ID: 17101679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of norA, norB and norC efflux pump genes mediating fluoroquinolones resistance in MRSA isolates.
    Hamady AB; Abd El-Fadeal NM; Imbaby S; Nassar HM; Sakr MG; Marei YE
    J Infect Dev Ctries; 2024 Mar; 18(3):399-406. PubMed ID: 38635612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
    Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V
    J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
    J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoguanidine hydrazones (AGH's) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump.
    Dantas N; de Aquino TM; de Araújo-Júnior JX; da Silva-Júnior E; Gomes EA; Gomes AAS; Siqueira-Júnior JP; Mendonça Junior FJB
    Chem Biol Interact; 2018 Jan; 280():8-14. PubMed ID: 29208359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
    Rath SK; Singh S; Kumar S; Wani NA; Rai R; Koul S; Khan IA; Sangwan PL
    Bioorg Med Chem; 2019 Jan; 27(2):343-353. PubMed ID: 30552006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.